INO-3112

DNA plasmid encoding interleukin-12 and HPV DNA plasmids · Inovio Pharmaceuticals

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for INO-3112, covering 2016-05-13 to 2024-07-09. Get the full timeline:

Most recent: Clinical Trial Update: DNA Plasmid-encoding Interleukin-12/HPV DNA Plasmids Therapeutic Vaccine INO-3112 and Durvalumab in Treating Patients With Recurrent or Metastatic Human Papillomavirus Associated Cancers [Phase 2]

See pricing